BofA Securities Thinks Regenxbio Inc. (RGNX) Can More Than Double After Meeting with Management
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham reiterated a Buy rating and $60.00 price target on Regenxbio Inc. (NASDAQ: RGNX) after meeting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
